Filing Details

Accession Number:
0001144204-15-001518
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-09 12:41:49
Reporting Period:
2014-12-26
Filing Date:
2015-01-09
Accepted Time:
2015-01-09 12:41:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453001 Vaccinogen Inc VGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361393 Georg Ture Anders Halldin Odlingsvagen 10
Alta V7 SE-13836
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-26 934,580 $5.50 934,580 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2014-12-26 272,727 $5.50 272,727 $6.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
272,727 2014-12-26 2019-12-26 No 4 P Direct
Footnotes
  1. The reported securities include 909,091 units purchased by the reporting persons for $5.50 per unit. Each unit consists of one share of common stock and one warrant to purchase three tenths (0.3) of a share of common stock. Pursuant to the terms of the subscription agreement under which the reporting person purchased the units, the reporting persons received additional "adjustment" shares of common stock as if the purchase price of the common stock was $5.35 per share.